Clinical Trials · NCT00123253
TH9507 in Patients With HIV-Associated Lipodystrophy
- Phase
- Phase 3
- Recruitment status
- Completed
- Sponsor
- Theratechnologies
- Enrollment
- 412
- Start date
- Jun 2005
- Locations
- 42 sites, United States, Canada
- Primary endpoint
- Visceral adipose tissue (VAT)